These processes can be blocked by either CypA inhibitors or CD147 antibodies, making the CypA/CD147 axis a potential target for the treatment of human cancers or inflammatory diseases.87 Therefore, understanding the molecular mechanism of CypA/CD147 interaction may have therapeutic value, especially in the treatment of cancer. This evidence concerns the gene BSG and cancer.